Greece vs Montenegro: The number of people with susceptibility test result for rifampicin
Greece
55
in 2021
Montenegro
55
in 2021
Greece rank
121st
Montenegro rank
121st
The number of people with susceptibility test result for rifampicin over time
- Greece
- Montenegro
How they compare
Greece currently reports 55 against 55 in Montenegro, a difference of 0.
The two have swapped places 1 time across 5 shared years of data; in 2017 it was Greece ahead.
Greece ranks 121st and Montenegro ranks 121st of 155 countries.
Greece has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Greece | Montenegro | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 149.33 | 57 | 92.33 | Greece |
| 2020s | 159 | 42 | 117 | Greece |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Greece or Montenegro?
- Greece, at 55 against 55 in Montenegro as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Greece and Montenegro?
- 0, with Greece ahead.
- How many years of comparable data are there for Greece and Montenegro?
- 5 years are reported by both, from 2017 to 2021.
- How do Greece and Montenegro rank globally for the number of people with susceptibility test result for rifampicin?
- Greece ranks 121st and Montenegro ranks 121st of 155 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid refreshes it automatically from the source and publishes the full history for both places.